Sexually Transmitted Infections Treatment Guidelines, 2021

• Published in: MMWR. Recommendations and reports Vol. 70; no. 4; pp. 1 - 187
• Main Authors: Workowski, Kimberly A, Bachmann, Laura H, Chan, Philip A, Johnston, Christine M, Muzny, Christina A, Park, Ina, Reno, Hilary, Zenilman, Jonathan M, Bolan, Gail A
• Format: Journal Article
• Language: English
• Published: United States U.S. Center for Disease Control 23.07.2021; Centers for Disease Control and Prevention
• Subjects: Anniversaries; Campylobacter; Centers for Disease Control and Prevention, U.S; Disease prevention; Feces; Gonorrhea; Guidelines; Health risks; Health services; Hepatitis C; Herpes simplex; Herpes viruses; HIV; Human immunodeficiency virus; Human papillomavirus; Humans; Infections; Inflammatory diseases; Literature reviews; Liver diseases; Men; Metronidazole; Pathogens; Pelvic inflammatory disease; Primary care; Recommendations and Reports; Risk analysis; Risk factors; Sexual assault; Sexually transmitted diseases; Sexually Transmitted Diseases - therapy; STD; Syphilis; United States; Vaccines; Vaginosis; Viruses; United States
• ISSN: 1057-5987; 1545-8601; 1545-8601
• DOI: 10.15585/mmwr.rr7004a1

These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.